 |
Clinical Trials Ventracor is conducting a clinical trial to gather data to support a CE marking application and approval to sell in Europe. Ventracor’s submission to the FDA for permission to conduct a clinical trial in the USAwill be made before the end of 2004. Enrolment in the Pilot Trial to establish the safety of the VentrAssist™ at The Alfred hospital in Melbourne has been closed. The VentrAssist™ is designed as a permanent solution for patients suffering congestive heart failure and no longer responding to currently available medical therapy. Throughout the clinical trial process, our main focus will be to ensure the privacy, wellbeing and dignity of individual patients taking part. Medical professionals interested in taking part in future trials should contact Dr John Woodard
T : 61 2 9404 3100
Shareholders and anyone interested in our progress can register here to receive our news updates. |
© Copyright Ventracor 2002 All rights reserved Ventracor Limited ABN 46 003 180 372 |
||||||
|
||||||
| | | | | | ||||||
